APREPITANT 40 mg/1 (Aprepitant CAPSULE) 40 mg/1

Aprepitant 40 mg capsules are used to prevent nausea and vomiting caused by chemotherapy. This antiemetic medication is designed to block specific receptors in the brain.

Strength

40 mg/1

Pack Size

5 BLISTER PACK in 1 CARTON (13668-591-82) / 1 CAPSULE in 1 BLISTER PACK (13668-591-80)

Manufacturer / TM Owner

Torrent Pharmaceuticals Limited

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Aprepitant 40 mg capsules are primarily used to prevent nausea and vomiting associated with chemotherapy. This medication works by blocking neurotransmitters in the brain that trigger these symptoms. It is often prescribed as part of a combination therapy to enhance its effectiveness. Patients may wonder, 'What is aprepitant used for?' and the answer is that it is specifically targeted at managing chemotherapy-induced nausea and vomiting.

Side Effects

Common effects of aprepitant 40 mg capsules may include headache, fatigue, and constipation. Some users might experience dizziness or diarrhea. These effects vary from person to person and are generally mild to moderate in nature.

Precautions & Warnings

Aprepitant 40 mg capsules should be handled with care. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. Patients with a history of severe liver disease should consult their doctor before using this medication. Always store the capsules in a cool, dry place away from direct sunlight.

Avoid Interactions

Aprepitant 40 mg capsules may interact with other medications, including those metabolized by the liver's cytochrome P450 enzymes. It is advisable to inform your healthcare provider about all medications you are currently taking to avoid potential interactions. Alcohol consumption should be limited while using this medication.

Frequently Asked Questions

Aprepitant is used to prevent nausea and vomiting caused by chemotherapy.

Store aprepitant capsules in a cool, dry place away from direct sunlight.

Common side effects may include headache, fatigue, constipation, dizziness, and diarrhea.

Aprepitant may interact with other medications, so it is important to consult a healthcare provider before combining it with other drugs.

Patients with severe liver disease should consult their doctor before using aprepitant.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.